Cardiovascular effects of SGLT‐2 inhibitors: What we have learned from cardiovascular outcome trials and what we still need to understand
2019 ◽
Vol 35
(4)
◽
pp. e3124
◽
2017 ◽
Vol 9
(4)
◽
pp. 347-360
◽
2020 ◽
Vol 22
(5)
◽
pp. 817-827
◽